» Articles » PMID: 19073768

Interaction Effect of Genetic Polymorphisms in Glucokinase (GCK) and Glucokinase Regulatory Protein (GCKR) on Metabolic Traits in Healthy Chinese Adults and Adolescents

Overview
Journal Diabetes
Specialty Endocrinology
Date 2008 Dec 17
PMID 19073768
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Recent studies in European populations have reported a reciprocal association of glucokinase regulatory protein (GCKR) gene with triglyceride versus fasting plasma glucose (FPG) levels and type 2 diabetes risk. GCKR is a rate-limiting factor of glucokinase (GCK), which functions as a key glycolytic enzyme for maintaining glucose homeostasis. We examined the associations of two common genetic polymorphisms of GCKR and GCK with metabolic traits in healthy Chinese adults and adolescents.

Research Design And Methods: Two single nucleotide polymorphisms (SNPs), rs780094 at GCKR and rs1799884 at GCK, were genotyped in 600 healthy adults and 986 healthy adolescents. The associations of these SNPs with metabolic traits were assessed by linear regression adjusted for age, sex, and/or BMI. We also tested for the epistasis between these two SNPs and performed a meta-analysis among European and Asian populations.

Results: The T-allele of GCKR rs780094 was associated with increased triglycerides (P = 5.4 x 10(-7)), while the A-allele of GCK rs1799884 was associated with higher FPG (P = 3.1 x 10(-7)). A novel interaction effect between the two SNPs on FPG was also observed (P = 0.0025). Meta-analyses strongly supported the additive effects of the two SNPs on FPG and triglycerides, respectively. CONCLUSIONS;- In support of the intimate relationship between glucose and lipid metabolisms, GCKR and GCK genetic polymorphisms interact to increase FPG in healthy adults and adolescents. These risk alleles may contribute to increased diabetes risk in subjects who harbor other genetic or environmental/lifestyle risk factors.

Citing Articles

A genotype-guided prediction model for the incidence of persistent acute kidney injury following lung transplantation.

Du W, Wang X, Zhang D, Chen W, Zuo X, Li P BMC Nephrol. 2024; 25(1):458.

PMID: 39696008 PMC: 11654156. DOI: 10.1186/s12882-024-03871-w.


Glucokinase regulatory protein rs780094 polymorphism is associated with type 2 diabetes mellitus, dyslipidemia, non-alcoholic fatty liver disease, and nephropathy.

Madhoun A World J Diabetes. 2024; 15(5):814-817.

PMID: 38766433 PMC: 11099372. DOI: 10.4239/wjd.v15.i5.814.


Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.

Chow E, Wang K, Lim C, Tsoi S, Fan B, Poon E Diabetes. 2022; 72(2):299-308.

PMID: 36342518 PMC: 9871194. DOI: 10.2337/db22-0708.


TBXAS1 Gene Polymorphism Is Associated with the Risk of Ischemic Stroke of Metabolic Syndrome in a Chinese Han Population.

Peng J, Lu F, Zhong M, Zhao Y, Wang Z, Zhang W Dis Markers. 2022; 2022:9717510.

PMID: 35923246 PMC: 9343182. DOI: 10.1155/2022/9717510.


Evaluating machine learning-powered classification algorithms which utilize variants in the GCKR gene to predict metabolic syndrome: Tehran Cardio-metabolic Genetics Study.

Akbarzadeh M, Alipour N, Moheimani H, Zahedi A, Hosseini-Esfahani F, Lanjanian H J Transl Med. 2022; 20(1):164.

PMID: 35397593 PMC: 8994379. DOI: 10.1186/s12967-022-03349-z.


References
1.
DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

2.
Van Schaftingen E, Vandercammen A, Detheux M, Davies D . The regulatory protein of liver glucokinase. Adv Enzyme Regul. 1992; 32:133-48. DOI: 10.1016/0065-2571(92)90013-p. View

3.
Gloyn A . Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum Mutat. 2003; 22(5):353-62. DOI: 10.1002/humu.10277. View

4.
Vaxillaire M, Cavalcanti-Proenca C, Dechaume A, Tichet J, Marre M, Balkau B . The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes. 2008; 57(8):2253-7. PMC: 2494697. DOI: 10.2337/db07-1807. View

5.
Weedon M, Clark V, Qian Y, Ben-Shlomo Y, Timpson N, Ebrahim S . A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. Am J Hum Genet. 2006; 79(6):991-1001. PMC: 1698701. DOI: 10.1086/509517. View